SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 237 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is 0.39 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $392,000 | -14.6% | 15,569 | -29.4% | 0.03% | +86.7% |
| Q3 2020 | $459,000 | -87.2% | 22,037 | -85.4% | 0.02% | -83.9% |
| Q2 2020 | $3,590,000 | -45.1% | 151,166 | -58.4% | 0.09% | -45.9% |
| Q1 2020 | $6,534,000 | -19.5% | 363,200 | +6.1% | 0.17% | +50.9% |
| Q4 2019 | $8,121,000 | -43.5% | 342,351 | -34.6% | 0.11% | -32.9% |
| Q3 2019 | $14,384,000 | +16.3% | 523,425 | +40.0% | 0.17% | -29.2% |
| Q2 2019 | $12,371,000 | +16.4% | 373,866 | +23.3% | 0.24% | +12.1% |
| Q1 2019 | $10,628,000 | +11.6% | 303,300 | +5.8% | 0.21% | +4.4% |
| Q4 2018 | $9,527,000 | +698.6% | 286,785 | +1110.7% | 0.20% | +720.0% |
| Q3 2018 | $1,193,000 | +122.2% | 23,688 | +164.1% | 0.02% | +78.6% |
| Q2 2018 | $537,000 | -23.8% | 8,971 | -41.7% | 0.01% | -30.0% |
| Q1 2018 | $705,000 | – | 15,395 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 426,500 | $11,754,340 | 3.96% |
| ASHFORD CAPITAL MANAGEMENT INC | 916,747 | $25,274,715 | 3.72% |
| ARMISTICE CAPITAL, LLC | 5,092,000 | $140,386,440 | 2.15% |
| S&T BANK/PA | 215,578 | $5,943 | 1.15% |
| Aristotle Capital Boston, LLC | 1,187,981 | $32,752,634 | 1.06% |
| RICE HALL JAMES & ASSOCIATES, LLC | 544,468 | $15,010,983 | 0.95% |
| Tributary Capital Management, LLC | 352,429 | $9,716,468 | 0.92% |
| Bridge City Capital, LLC | 65,297 | $1,800,238 | 0.91% |
| Integral Health Asset Management, LLC | 220,000 | $6,065,400 | 0.84% |
| Retirement Planning Co of New England, Inc. | 51,608 | $1,422,833 | 0.79% |